Login / Signup
Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses.
Xuenian Chen
Tongfei Shi
Chao Yang
Fangman Chen
Xuan He
Kunbao Zhang
Hanze Hu
Lulu Cai
Kam W Leong
Dan Shao
Published in:
Signal transduction and targeted therapy (2022)
Keyphrases
</>
sars cov
immune response
respiratory syndrome coronavirus
dendritic cells
toll like receptor